Publications by authors named "Neil E Martin"

101Publications

Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancer.

Brachytherapy 2020 Oct 29. Epub 2020 Oct 29.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.

View Article and Find Full Text PDF
October 2020

Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer.

Urol Oncol 2020 Sep 10;38(9):735.e9-735.e15. Epub 2020 Jul 10.

Harvard Medical School, Boston, MA; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA. Electronic address:

View Article and Find Full Text PDF
September 2020

Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.

Cancer 2019 09 31;125(18):3164-3171. Epub 2019 May 31.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.

View Article and Find Full Text PDF
September 2019

Now You're Speaking My Language: Getting Patient-reported Outcomes to Talk to One Another.

Authors:
Neil E Martin

Eur Urol 2019 05 5;75(5):731-732. Epub 2019 Feb 5.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
May 2019

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.

Eur Urol 2019 01 24;75(1):35-41. Epub 2018 Oct 24.

Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
January 2019

Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce.

Am J Med 2018 05 16;131(5):517-523. Epub 2018 Mar 16.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. Electronic address:

View Article and Find Full Text PDF
May 2018

Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.

Eur Urol 2018 08 22;74(2):146-154. Epub 2018 Feb 22.

Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
August 2018

Impact of a clinical pathway tool on appropriate palliative radiation therapy for bone metastases.

Pract Radiat Oncol 2018 Jul - Aug;8(4):266-274. Epub 2017 Dec 8.

Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article and Find Full Text PDF
December 2018

Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.

Clin Genitourin Cancer 2018 06 9;16(3):226-234. Epub 2017 Nov 9.

Harvard Medical School, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article and Find Full Text PDF
June 2018

Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer.

Int J Radiat Oncol Biol Phys 2017 11 31;99(4):904-911. Epub 2017 Jul 31.

Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article and Find Full Text PDF
November 2017